ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Sleep Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,938Medicare Part D Prescriptions Filled, Including Refills
$538K Total Retail Price of All Prescriptions
277 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 354 255 S3
LEVOTHYROXINE SODIUM 228 130
LISINOPRIL 222 161
SIMVASTATIN 212 149
FUROSEMIDE 162 146
AMLODIPINE BESYLATE 154 126
GABAPENTIN 152 112
TORSEMIDE 136 82
DONEPEZIL HCL 135 122
ALENDRONATE SODIUM 125 95
OMEPRAZOLE 119 80
METFORMIN HCL 115 59
PRAVASTATIN SODIUM 114 77
SPIRONOLACTONE 112 61
CLOPIDOGREL 110 97
TRAMADOL HCL 102 72
CITALOPRAM HBR 93 80
CARVEDILOL 91 55
MIRTAZAPINE 89 77
KLOR-CON M20 88 61
METOPROLOL SUCCINATE 84 62
CYMBALTA 82 42
POTASSIUM CHLORIDE 79 46
ZOLPIDEM TARTRATE 77 57
ALLOPURINOL 75 48
PLAVIX 74 63
GLIMEPIRIDE 71 36
NEXIUM 71 47
RANITIDINE HCL 70 57
POLYETHYLENE GLYCOL 3350 70 55
LANTUS 68 37
TAMSULOSIN HCL 64 35
ISOSORBIDE MONONITRATE ER 62 62
NOVOLIN R 58 25
WARFARIN SODIUM 57 56
ATORVASTATIN CALCIUM 55 34
HYDROCHLOROTHIAZIDE 54 32
LYRICA 52 22
MELOXICAM 51 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.